calibrate glp-1 Medication in the Program: Introducing Wegovy® (Semaglutide) Glp1 with optumRX and calibrate.

Fleming GA, Petrie JR, Bergenstal RM, Holl RW, Peters AL, Heinemann L (2020) Diabetes digital app technology: benefits, challenges, and recommendations

adults will be on obesity medications by 2030, indicating substantial growth potential

Preventive Services Task Force (USPSTF), the American Heart Association/American College of Cardiology/The Obesity Society (AHA/ACC/TOS), and the European Association for the Study of Obesity (EASO) each recommend multicomponent interventionsincluding caloric targets, physical activity, goal-setting, self-monitoring, and problem-solvingover a duration of at least six months to achieve clinically meaningful weight loss [35,36,37]

62 Another study demonstrated that the obesity control dose of liraglutide can significantly reduce the risk of progression to diabetes in patients with prediabetes